..
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-07T11-29-08_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-08T11-05-45_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-09T10-53-43_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-12T10-43-26_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-13T10-37-30_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-14T12-30-13_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-15T11-05-49_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-16T11-06-09_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-19T11-12-19_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-20T11-40-34_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-21T10-51-54_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-22T10-54-20_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-23T10-11-24_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-27T11-12-51_ogen.nwb
sub-108-411_ses-Opto-DMS-Inhibitory-EYFP-2020-10-28T11-22-06_ogen.nwb